Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

Glenmark Pharma share price target ... a consistent turnaround in the company's overall performance. Related News | Aurobindo ...

Auditor/Auditors for Glenmark Pharmaceuticals Ltd is/are Suresh Surana & Associates LLP. In the main management ... advice or guarantee for any specific performance/ returns advice or considered ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

2024 Indian drugmaker Glenmark Life Sciences posted a 13% rise in third-quarter profit on Tuesday, helped by a robust performance by its core active pharmaceutical ingredient (API) business.

Glenmark Pharmaceuticals rallies over 3% on plans to out-license molecule for pain management Glenmark Pharmaceuticals Ltd rallied as much as 3.4 per cent in trade on Monday, after media reports ...

Glenmark Pharmaceuticals has agreed to pay USD 25 million as part of a settlement with the US Department of Justice regarding a case related to the pricing of a generic drug. Glenmark ...

Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences ...

Glenmark Pharmaceuticals Inc., based in New Jersey and a subsidiary of the Mumbai-based Glenmark Pharmaceuticals, initiated a ...

Glenmark Life Sciences ... newer geographies in the global pharmaceutical industry, transition to specialty segments and strong domestic demand as per the management of the company.

Glenmark Life Sciences will reportedly launch its IPO on July 27. Parent company Glenmark Pharmaceuticals will ... central nervous system disease, pain management and diabetes, the company ...